Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory
Systemic lupus erythematosus (SLE) is an autoimmune disorder which can have neurological manifestations, including autoantibody targeting of the NMDA receptor. In this study, the authors GluN2A subunit is a target of SLE autoantibodies, using sample derived from patient.
Guardado en:
Autores principales: | Kelvin Chan, Jacquelyn Nestor, Tomás S. Huerta, Noele Certain, Gabrielle Moody, Czeslawa Kowal, Patricio T. Huerta, Bruce T. Volpe, Betty Diamond, Lonnie P. Wollmuth |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8fc9079fa874a23beb127b18897c7a5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
GluN2A and GluN2B NMDA receptors use distinct allosteric routes
por: Meilin Tian, et al.
Publicado: (2021) -
Unmasking GluN1/GluN3A excitatory glycine NMDA receptors
por: Teddy Grand, et al.
Publicado: (2018) -
A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors
por: Divyan A. Chopra, et al.
Publicado: (2017) -
Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors
por: Kristyna Skrenkova, et al.
Publicado: (2019) -
Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors
por: Jue Xiang Wang, et al.
Publicado: (2020)